Browsing publications by Dr Yvette Drew

Newcastle AuthorsTitleYearFull text
Dr Yvette Drew
Ajay Gupta
Professor Ruth Plummer
A Phase 1 Study of Oral or Intravenous Rucaparib in Combination in Combination with Platinum-Containing Chemotherapeutic Regimens: Analysis of Patients with Ovarian or Peritoneal Tumors2013
Dr Nicola Cresti
Dr Yvette Drew
Professor Ruth Plummer
A phase I study of oral rucaparib in combination with carboplatin2013
Bojidar Goranov
Dr Yvette Drew
Jonathon Graham
Dr Rachel Pearson
Academic opportunities within clinical oncology training2013
Dr Jane Margetts
Dr Yvette Drew
Dr Peter Stephens
Professor Alan Calvert
Professor Ruth Plummer
et al.
Erratum to: Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors (vol 31, pg 623, 2013 Doi: 10.1007/s10637-012-9843-5)2013
Dr Jane Margetts
Dr Yvette Drew
Professor Ruth Plummer
Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors2013
Dr Yvette Drew
Dr Evan Mulligan
Wan Vong
Huw Thomas
Suzanne Kyle
et al.
Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA22011
Rachel Daniel
Dr Agata Rozanska
Dr Evan Mulligan
Dr Yvette Drew
Huw Thomas
et al.
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-0146992010
Dr Asima Mukhopadhyay
Dr Ahmed Elattar
Dr Aiste McCormick
Sarah Wilkinson
Dr Yvette Drew
et al.
Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors2010
Dr Yvette Drew
Professor Ruth Plummer
The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer2010
Dr Evan Mulligan
Tomasz Zaremba
Dr Yvette Drew
Professor Ruth Plummer
Professor Nicola Curtin
et al.
[abstract] Validated sensitive immunological determination of PARP-1 protein levels and activity in cultured cells and human lymphocytes2009
12